Biophagy

Focus: Biophagy is a biotechnology company focused on identifying drugs that modulate autophagy, a cellular process with broad therapeutic potential. Based in Albuquerque, NM, the company operates as a pre-revenue or early-stage biotech with limited public disclosure of scale.

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Biophagy

AI assessmentNot Hiring

No open roles listed right now. Follow Biophagy to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

0/9 — Limited

Company HealthSolid

Pipeline

Early-stage

0 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Open Jobs (0)

No open positions listed yet.

Help build intelligence for Biophagy

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Opportunity to work at the forefront of autophagy modulation, an emerging and scientifically compelling field with applications across multiple therapeutic areas
Early-stage environment offers hands-on involvement in drug discovery and potential to shape company direction from the ground up
Location in Albuquerque provides lower cost of living and potential access to regional biotech and academic networks

Watch Out For

No active job postings and minimal public data suggest the company is not actively hiring or may have limited visibility in the talent market
Absence of disclosed funding, revenue, pipeline programs, and clinical trials indicates high execution risk and uncertain path to value creation
Pre-revenue status with no published financials or FDA programs creates significant uncertainty around runway, stability, and career advancement prospects

Generated by Claude from Biophagy's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo